Peptide record

TPDB91309

Nisin Z Nisin ZP Antibacterial Anticancer Antifungal Antiparasitic modified_plain modified
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91309
Nisin Z Nisin ZP
Antibacterial Anticancer Antifungal Antiparasitic
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF Antifungipept
modified_plain
Yes
A 34-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Cyclized N-terminal: Cyclized
Sequence
ITSISLCTPGCKTGALMGCNMKTATCNCSIHVSK
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
34 reviewed residue count
Cyclized Activity
L Activity
Cyclic Activity
Cyclized Activity
Antimicrobial Activity
Lactococcus lactis Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

79.22% cytotoxicity at 1000 µg/mL
Anticancer

Target

Colon Cancer
SW-480
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2017

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 132.4 ± 6.4 µM
Anticancer
132.4

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 3 Activity

Activity

IC50
IC50 = 137.3 ± 9.1 µM
Anticancer
137.3

Target

Lung Cancer
H-1299
Lung

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022